Targeting molecule and utilization thereof

Provided are: a targeting molecule targeting a target cell which is selected from the group consisting of a stellate cell, a myofibroblast, a cancer-associated fibroblast, a tumor cell and a cell expressing STRA6, said targeting molecule being selected from the group consisting of (1) a peptide cont...

Full description

Saved in:
Bibliographic Details
Main Authors NIITSU YOSHIRO, MINOMI KENJIRO, TAKAHASHI HIROKAZU, TERADA ERIKA
Format Patent
LanguageChinese
English
Published 23.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided are: a targeting molecule targeting a target cell which is selected from the group consisting of a stellate cell, a myofibroblast, a cancer-associated fibroblast, a tumor cell and a cell expressing STRA6, said targeting molecule being selected from the group consisting of (1) a peptide containing an amino acid sequence in the cell-binding region of RBP, (2) a variant peptide of the aforesaid peptide (1), said variant peptide having a comparable targeting ability to peptide (1), and (3) a peptide mimetic having a comparable targeting ability to peptide (1) or peptide (2); a targeting agent, a carrier, a complex and a medicinal composition each comprising the targeting molecule; a method for treating, examining, diagnosing or monitoring a disease related to the aforesaid target cell; a method for labeling, detecting or imaging the target cell, etc. 本发明涉及以选自由星状细胞、肌成纤维细胞、癌相关成纤维细胞、肿瘤细胞及STRA6表达细胞组成的组中的靶细胞为靶的靶向分子,含有该靶向分子的靶向剂、载体、复合物及医药组合物,对与所述靶细胞相关的疾病进行处置、检査、诊断或监测的方法及对所述靶细胞进行标记、监测或成像的方法等,所述靶向分子选自由下述(1)~(3)组成
Bibliography:Application Number: CN201580018185